Streamline your path from immunodiagnostic development to commercialization

Presented By:
Anthony Chiulli

Speaker Biography:
Anthony Chiulli is a Director of Protein & Cell Analysis Division, supporting Global OEM & Licensing at Thermo Fisher Scientific. In addition to Business Development, Anthony has had various roles in Product Management, Project Management and R&D over more than 20 years. Anthony has vast experience in supporting diagnostic and life science tool customers worldwide better utilize Thermo Fisher Scientific products as components of their Commercial products. Anthony, who has been issued patents related to ELISA product development, began his career as a Scientist both developing and manufacturing immunoassays.

Streamline your path from immunodiagnostic development to commercialization

Webinar Abstract:
Developing an immunodiagnostic assay is a partnership from initial development through launch. Thermo Fisher Scientific’s Global OEM & Licensing (GOaL) team supports our partners’ development and commercialization of immunodiagnostic assays using a wide array of products and technologies. Our team of subject matter experts use their many years of experience to help guide your reagent selections and confirm that the commercial rights and necessary licenses are in place for the components being sourced. Working together with the GOaL team can help to ensure consistent performance and security of supply of important reagents. Post-launch, we work with our partners to maintain performance through features such as lot-to-lot consistency and change notification. This webinar will provide immunodiagnostics developers with the insight required to accelerate commercialization, as well as an understanding of the products, technologies, and capabilities at our various Centers of Excellence.

Earn PACE Credits:
1. Make sure you're a registered member of LabRoots (
2. Watch the webinar on the LabRoots Website (
3. Click Here to get your PACE credits (Expiration date – NOV 03, 2023): (

LabRoots on Social:
SnapChat: labroots_inc
Be the first to comment